comprehensive -WSS

comprehensive

author：explore 2025-08-12 11:33:43 - browse：72

Doctor holding a clipboard. -- health coverage from STAT — Adobe

The momentum around weight loss drugs is about to get even bigger in the wake of Novo Nordisk’s announcement that its semaglutide drug Wegovy cut the risk of cardiovascular disease by 20% in its large SELECT trial.

The full results of the study, funded by Novo, will be presented at the American Heart Association meeting in November. Doctors and researchers say they expect the findings to have a big impact on how clinicians approach the treatment of both obesity and cardiovascular disease, as well as increase the likelihood that prescriptions for obesity drugs will be covered by insurance.

But experts who spoke with STAT also cautioned that the long-term safety and efficacy of Wegovy and other weight loss drugs remain unknown. The SELECT study has yet to be peer-reviewed, and not enough information is yet available to make independent assessments of the results.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： Hospital price transparency does save money, advocate argues

WSS

Elisabeth Bik tackles the widespread issue of research misconduct

Cholera vaccine supplies dangerously low, outbreaks surging

Senate committee scrutinizes Medicare Advantage brokers

CDC advisory group OKs chikungunya vaccine

Studies point to risks of excluding people with obesity from drug trials

Redefining sustainability for the pharmaceutical industry

focus

comprehensive

hotspot

23andMe had bad news about my health. I wish a person had delivered it

5 ways to address the shortage of health care workers

Moonlake's readout produced a cash windfall. Risks remain

The EU Joint Clinical Assessment needs to live up to its promise

Peter Hotez and the public health issue of online harassment

Laying a path for careers in science

How one medical school became remarkably diverse

Laying a path for careers in science

Medical leaders decry Supreme Court decision on affirmative action

Medicare isn't yet testing food as medicine

hotspot

Doctor of U.S. President Joe Biden says he is fit for duty

Pharmacists can make shortage drugs, but at what cost?

Pharmacists can make shortage drugs, but at what cost?

Virtual repurposing can help discover new uses for existing drugs

STAT Summit: How a Chicago ER doctor tackles gun violence

Impact of Dobbs ruling felt at reproductive medicine meeting

hotspot

explore

leisure time

leisure time